Sulfonylurea, thiazolidinedione risks vs metformin British cohort study
Links shared publicly online about this topic.
- 1,555total visits
Sulfonylurea, thiazolidinedione risks vs metformin British cohort study
Analysis of a huge British cohort of diabetics treated from 1990 to 2005 showed, not surprisingly, an excess mortality risk from treatment with the sulfonylureas compared with metformin; but it also failed to demonstrate an increased MI risk with rosiglitazone.
View full resource at theheart.org
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Avandia, Avandamet, Avandaryl, Glucophage
Most Recently Shared on December 4, 2009 at 4:18 pm By:
UK diabetic cohort analysis confirms sulfonylurea risks, adds to glitazone debate http://bit.ly/6pBaUk #heartwire
Advertisement
